Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 5, Status: Authorised

Pharmaceutical quality of inhalation and nasal products - Scientific guideline

Human medicines European public assessment report (EPAR): Benepali, etanercept, Date of authorisation: 13/01/2016, Revision: 27, Status: Authorised

HMA-EMA joint Network Data Steering Group meeting 27 June 2025

HMA-EMA joint Network Data Steering Group meeting - 28 May 2025

Referral: Veterinary medicinal products containing albendazole as a single active substance presented as oral suspension in sheep, albendazole Article 82 Procedure started, 24/07/2025

CooperSurgical Inc ART Media - Procedural steps and scientific information after initial consultation (archive)

Origio - Procedural steps and scientific information after initial consultation (archive)

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 10, Status: Authorised